IP Library Granted Patent US 9,440,089
Granted Patent B2
US 9,440,089 · App. 14/171,553 · Granted Sep 13, 2016

Apparatus and method for electromagnetic treatment of neurological injury or condition caused by a stroke

Inventors: Arthur A. Pilla (Oakland, NJ); Andre' A. DiMino (Woodcliff Lake, NJ); Iyer Viswanathan (Santa Clara, CA); Diana Casper (New York, NY); Berish Strauch (Rye, NY)
Assignee: Rio Grande Neurosciences, Inc.
A61N2/006A61N1/36014A61N2/004A61N1/36025
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,440,089
App. No.
14/171,553
Granted
Sep 13, 2016
Kind
B2
Abstract

Described herein are methods of treating neurological injury and conditions, in particular symptoms and complications arising from or caused by a stroke. These treatment methods can include the steps of generating a pulsed electromagnetic field from a pulsed electromagnetic field source and applying the pulsed electromagnetic field in proximity to a target region.

Claims (53)

1. A method for treating a neurological injury or condition caused by a stroke in a patient in need thereof, the method comprising:

placing a pulsed electromagnetic device comprising a pulsed electromagnetic field source external to a patient's head and in proximity to a target region for treatment through a skull;

generating a pulsed electromagnetic field from the pulsed electromagnetic field source wherein the pulsed electromagnetic field comprises bursts of between 15-40 MHz sinusoidal waves, wherein the bursts repeat at between 0.01 and 100 Hz;

applying the pulsed electromagnetic field through the skull to the target region affected by the neurological injury or condition caused by the stroke; and

reducing a physiological response to the neurological injury or condition by applying the pulsed electromagnetic field,

wherein the pulsed electromagnetic field has a strength of 200 milliGauss or less.

2. The method of claim 1 , wherein the physiological response is inflammation.

3. The method of claim 1 , wherein the physiological response is increased intracranial pressure.

4. The method of claim 1 , further comprising monitoring the physiological response; and continuing to apply the pulsed electromagnetic field until an acceptable level of the physiological response is reached.

5. The method of claim 4 , wherein the physiological response is increased intracranial pressure and the acceptable level is below about 20 mmHg.

6. The method of claim 1 , wherein generating the pulsed electromagnetic field comprises a 2 msec burst of 27.12 MHz sinusoidal waves repeating at 2 Hz.

7. The method of claim 1 , wherein the pulsed electromagnetic field comprises a 3 msec burst of 27.12 MHz sinusoidal waves repeating at 2 Hz.

8. The method of claim 1 , wherein the pulsed electromagnetic field comprises a 4 msec burst of 27.12 MHz sinusoidal waves repeating at 2 Hz.

9. The method of claim 1 , wherein the pulsed electromagnetic field comprises about a 1 msec to about a 10 msec burst of 27.12 MHz sinusoidal waves repeating at about 1 Hz to about 10 Hz.

10. The method of claim 1 , wherein the pulsed electromagnetic field comprises an ISM carrier frequency modulated at about a 1 msec to about a 10 msec burst repeating at about 1 Hz to about 10 Hz.

11. The method of claim 1 , wherein the physiological system is the central nervous system.

12. The method of claim 1 , wherein the electromagnetic field comprises a waveform that modulates at least one biological signaling pathway.

13. The method of claim 1 , wherein the target region is a brain of the patient.

14. A method for treating a neurological injury or condition caused by a stroke in a patient in need thereof, the method comprising:

placing a pulsed electromagnetic device comprising a pulsed electromagnetic field source external to a patient's head and in proximity to a target region for treatment through a skull;

generating a first pulsed electromagnetic field from the pulsed electromagnetic field source wherein the pulsed electromagnetic field comprises bursts of between 15-40 MHz sinusoidal waves, wherein the bursts repeat at between 0.01 and 100 Hz;

applying the first pulsed electromagnetic field through the skull to the target region affected by the neurological injury or condition caused by the stroke for a first treatment interval;

reducing a physiological response to the neurological injury or condition by applying the first pulsed electromagnetic field;

discontinuing the application of the first pulsed electromagnetic field for an inter-treatment period greater than zero; and

externally applying a second pulsed electromagnetic field in proximity to the target region through the skull,

wherein the first and second pulsed electromagnetic fields each have strengths of 200 milliGauss or less.

15. The method of claim 14 , wherein the first and second pulsed electromagnetic fields are substantially the same.

16. The method of claim 14 , further comprising monitoring the physiological response; and modifying the first pulsed electromagnetic field to the second pulsed electromagnetic field in response to the monitoring step.

17. The method of claim 14 , further comprising monitoring the physiological response; and discontinuing treatment once an acceptable level of the physiological response is reached.

18. The method of claim 14 , further comprising attenuating inflammatory cytokines and growth factors at the target region by applying the first pulsed electromagnetic field or the second pulsed electromagnetic field to the target region.

19. The method of claim 14 , further comprising accelerating the healing of the target region by applying the first pulsed electromagnetic field or the second pulsed electromagnetic field to the target region.

20. The method of claim 14 , wherein applying the first pulsed electromagnetic field in proximity to a target region affected by the neurological injury or condition caused by the stroke to reduce a physiological response comprises reducing a concentration of IL-1β.

21. The method of claim 14 , further comprising increasing a growth factor in the target region.

22. The method of claim 21 , wherein increasing a growth factor in the target region enhances angiogenesis.

23. The method of claim 21 , wherein increasing a growth factor in the target region enhances nervous tissue regeneration.

24. The method of claim 21 , wherein the growth factor is selected from the group consisting of FGF-2, VEGF, and BMP.

25. The method of claim 14 , wherein the target region is a brain of the patient.

26. A method for treating a neurological injury or condition caused by a stroke in a patient in need thereof, the method comprising:

placing a pulsed electromagnetic device comprising a pulsed electromagnetic field source external to a patient's head and in proximity to a target region for treatment through a skull;

generating a pulsed electromagnetic field from the pulsed electromagnetic field source wherein the pulsed electromagnetic field comprises bursts of between 15-40 MHz sinusoidal waves, wherein the bursts repeat at between 0.01 and 100 Hz;

applying the pulsed electromagnetic field through the skull to the target brain region affected by the neurological injury or condition caused by the stroke; and

modulating microglia activation in the target brain region and reducing a physiological response to the neurological injury or condition by applying the pulsed electromagnetic field,

wherein the pulsed electromagnetic field has a strength of 200 milliGauss or less.

27. The method of claim 26 , wherein modulating microglia activation comprises reducing microglia activation in the target brain region.

28. A method of promoting neurological repair or growth following a neurological injury or condition caused by a stroke comprising:

placing a treatment coil of a self-contained, lightweight, and portable treatment apparatus externally to a target treatment site in need of repair or development, wherein the treatment apparatus comprises a conformable coil having one or more turns of wire and a control circuit;

generating an electromagnetic field using the treatment coil wherein the electromagnetic field comprises bursts of between 15-40 MHz sinusoidal waves, wherein the bursts repeat at between 0.01 and 100 Hz;

delivering the electromagnetic field to the target treatment site through a skull using the treatment coil; and

reducing a physiological response to the neurological injury or condition by delivering the electromagnetic field,

wherein the pulsed electromagnetic field has a strength of 200 milliGauss or less.

29. The method of claim 28 , further comprising delivering the electromagnetic field for a period of about 1 minute to about 240 minutes.

30. The method of claim 28 , wherein the physiological response is a cognitive deficiency.

31. The method of claim 28 , wherein the target treatment site is a brain.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2024
From: ENDONOVO THERAPEUTICS, INC.
To: SOFPULSE, INC.
Reel/Frame 067933/0673 →
LICENSE Recorded Sep 24, 2019
From: RIO GRANDE NEUROSCIENCES, INC., ASSIGNOR TO ENDONOVO THERAPEUTICS INC.
To: AAH HOLDINGS LLC
Reel/Frame 050475/0809 →
SECURITY AGREEMENT Recorded Feb 1, 2018
From: ENDONOVO THERAPEUTICS, INC.
To: STEVEN M. GLUCKSTERN
Reel/Frame 045221/0863 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2018
From: RIO GRANDE NEUROSCIENCES, INC.
To: ENDONOVO THERAPEUTICS INC.
Reel/Frame 044644/0182 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2016
From: IVIVI HEALTH SCIENCES, LLC
To: RIO GRANDE NEUROSCIENCES, INC.
Reel/Frame 037445/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2015
From: IVIVI HEALTH SCIENCES, LLC
To: RIO GRANDE NEUROSCIENCES, INC.
Reel/Frame 037394/0244 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2014
From: PILLA, ARTHUR A.; DIMINO, ANDRE' A.; VISWANATHAN, IYER; CASPER, DIANA; STRAUCH, BERISH
To: IVIVI HEALTH SCIENCES, LLC
Reel/Frame 034093/0920 →
Continuity (25)
Continuation In Part 13252114 · Oct 3, 2011
Continuation In Part 13801789 · Mar 13, 2013
Continuation 12819956 · Jun 21, 2010
Continuation In Part 12772002 · Apr 30, 2010
Continuation 11003108 · Dec 3, 2004
Continuation In Part 11114666 · Apr 26, 2005
Continuation In Part 11110000 · Apr 19, 2005
Continuation In Part 11369308 · Mar 6, 2006
Continuation In Part 11369309 · Mar 6, 2006
Continuation In Part 11223073 · Sep 10, 2005
Continuation In Part 11339204 · Jan 25, 2006
Continuation In Part 11818065 · Jun 12, 2007
Continuation In Part 11903294 · Sep 20, 2007
Continuation In Part 11977043 · Oct 22, 2007
Provisional Application 61389038 · Oct 1, 2010
Provisional Application 61456310 · Nov 4, 2010
Provisional Application 60527327 · Dec 5, 2003
Provisional Application 60564887 · Apr 26, 2004
Provisional Application 60563104 · Apr 19, 2004
Provisional Application 60658967 · Mar 7, 2005
Provisional Application 60658968 · Mar 7, 2005
Provisional Application 60812841 · Jun 12, 2006
Provisional Application 60846126 · Sep 20, 2006
Provisional Application 60852927 · Oct 20, 2006
Related Publication 20140213843A1 · Jul 31, 2014